Literature DB >> 10880162

Expression of vascular endothelial growth factor in liver tissues of hepatitis B.

J Yan1, W Chen, Y Ma, X Sun.   

Abstract

OBJECTIVE: To study the relationship between vascular endothelial growth factor (VEGF) and grading (G) and staging (S) of hepatitis B (HB).
METHODS: Immunohistochemical staining was performed with VEGF monoclonal antibody in 250 biopsies of HB.
RESULTS: The types of VEGF expression in liver tissues were of plasma type, sinusoidal membrane type and sinusoidal endothelial cell type. VEGF was mainly secreted by hepatocytes, and was also positively expressed in liver sinusoidal endothelial cells, fat-storing cells, myofibroblast and monomorphological nuclear cells. And it was negative in vascular endothelial cells and hepatocytes which had not significant damage, suggesting that the expression of VEGF was enhanced with the increase of G (chi(2)=90.43, P<0.01). VEGF was positively expressed on those whose scores of S were lower, while strongly positively expressed on those whose scores of S were higher. There was also a significant difference between them (chi(2)=115.74, P<0.01).
CONCLUSION: The expressions of VEGF are related to G and S of HB

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10880162

Source DB:  PubMed          Journal:  Zhonghua Gan Zang Bing Za Zhi        ISSN: 1007-3418


  4 in total

1.  Vascular endothelial growth factor attenuates hepatic sinusoidal capillarization in thioacetamide-induced cirrhotic rats.

Authors:  Hao Xu; Bao-Min Shi; Xiao-Fei Lu; Feng Liang; Xing Jin; Tai-Huang Wu; Jian Xu
Journal:  World J Gastroenterol       Date:  2008-04-21       Impact factor: 5.742

2.  IL-17 promotes tumor angiogenesis through Stat3 pathway mediated upregulation of VEGF in gastric cancer.

Authors:  Xiaoqin Wu; Tao Yang; Xiang Liu; Jia Nian Guo; Tingting Xie; Yuanwei Ding; Manpeng Lin; Hui Yang
Journal:  Tumour Biol       Date:  2015-11-13

3.  Yiguanjian decoction and its ingredients inhibit angiogenesis in carbon tetrachloride-induced cirrhosis mice.

Authors:  Ya-Ning Zhou; Yong-Ping Mu; Wen-Wei Fu; Bing-Bing Ning; Guang-Li Du; Jia-Mei Chen; Ming-Yu Sun; Hua Zhang; Yi-Yang Hu; Cheng-Hai Liu; Lie-Ming Xu; Ping Liu
Journal:  BMC Complement Altern Med       Date:  2015-10-01       Impact factor: 3.659

4.  VEGF promotes gastric cancer development by upregulating CRMP4.

Authors:  Sile Chen; Xinhua Zhang; Jianjun Peng; Ertao Zhai; Yulong He; Hui Wu; Chuangqi Chen; Jinping Ma; Zhao Wang; Shirong Cai
Journal:  Oncotarget       Date:  2016-03-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.